Abacavir
Carbocyclic nucleoside reverse transcriptase inhibitor supplied as sulfate salt — USP/EP/BP grade — for oral tablet manufacturing. Sourced for first-line HIV-1 combination antiretroviral therapy.
← All CategoriesAPI Portfolio
Anti Retroviral APIs
Nucleoside, non-nucleoside, and protease-inhibitor APIs targeting HIV replication cycles. Supplied in USP/EP/BP grade for fixed-dose combination ART manufacturing across global health procurement channels.
Regulatory ReadyCOA, DMF & CEP supportUSP / EP / BPPharmacopoeial grade APIsFull TraceabilityBatch-to-batch documentation
Request Anti Retroviral API Catalogue
All Anti Retroviral APIs
Page 1 of 1
11 APIs available
Didanosine
Purine nucleoside reverse transcriptase inhibitor in USP/EP grade for oral tablet and capsule manufacturing. Sourced for combination antiretroviral therapy in treatment-experienced HIV patients.
Efavirenz
Non-nucleoside reverse transcriptase inhibitor in USP grade for oral tablet manufacturing. Core API in first-line fixed-dose combination regimens for HIV-1 infection.
Indinavir Sulphate
HIV protease inhibitor supplied as sulfate salt for oral capsule manufacturing. Sourced for combination antiretroviral therapy in HIV-1 and AIDS management protocols.
Lamivudine
Nucleoside reverse transcriptase inhibitor in USP/EP/BP/IP grade for oral tablet manufacturing. Widely sourced for HIV-1, HIV-2, and chronic hepatitis B combination therapy.
Lopinavir
HIV protease inhibitor in USP/EP grade for oral tablet manufacturing, typically co-formulated with ritonavir as a pharmacokinetic booster. Sourced for combination ART regimens.
Nelfinavir Mesylate
HIV protease inhibitor supplied as mesylate salt — USP grade — for oral tablet and powder formulation manufacturing. Sourced for combination antiretroviral therapy in adult and paediatric HIV-1 management.
Nevirapine
Non-nucleoside reverse transcriptase inhibitor in USP/EP grade for oral tablet and suspension manufacturing. Sourced for first-line HIV-1 therapy and prevention of mother-to-child transmission.
Ritonavir
HIV protease inhibitor in USP/EP grade for oral tablet manufacturing, primarily used as a pharmacokinetic booster for other protease inhibitors. Core component of multiple fixed-dose ART combinations.
Saquinavir Mesylate
HIV protease inhibitor supplied as mesylate salt for oral tablet manufacturing. Sourced for combination antiretroviral therapy regimens in treatment-experienced HIV-1 patients.
Stavudine
Nucleoside reverse transcriptase inhibitor in USP grade for oral capsule and solution manufacturing. Historically sourced for first-line HIV-1 therapy in resource-limited combination regimens.
WHO-GMP Certified Sources
Global Delivery
Regulatory Support
Consistent Quality
Secure Packaging / Custom Options